http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2491338-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d81b982a1afcbd6a95ca1e3d7c9b2445 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 |
filingDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6909a568e7f74197af55016edecf6395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7236f9d6194fa13a2273695a49fd5293 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c33cf7a09062a18ac6c28a95117429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e849ae8cb56e403a5ec492260ba411a1 |
publicationDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2491338-C2 |
titleOfInvention | Using monoclonal antibodies for identifying yamagata or victorian influenza b viral evolution line, hybridoma 4h7 strain for preparing monoclonal antibodies used to identify influenza b viruses in yamagata branch, hybridoma b/4h1 strain for preparing monoclonal antibodies used to identify influenza b viruses in victorian branch |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention discloses using the monoclonal antibodies (MCAs) produced by the hybridomas B/4H1 and 4H7 and directed to variable determinants as a part of influenza B virus proteins. The hybridoma B/4H1 and 4H7 strains are deposited in the Russian Collection of Vertebral Cell Cultures (RKKK P) under Nos. 719 D and 720 D, respectively. The two current influenza B viral evolution lines are identified with using the MCAs B/4H1 and MCAs 4H7 directed to variable determinants of Victorian-type and Yamagata-type influenza B hemagglutinin, respectively. n EFFECT: using the prepared MCA kit enables identifying the newly recovered influenza B viruses Besides, the MCAs under the invention may be used to study the antigenic structure and variability of this agent, to identify them as belonging to a specific evolution line; the MCAs may be also used to construct the diagnostic test systems. n 3 cl, 12 dwg, 8 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2645114-C2 |
priorityDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.